1610 related articles for article (PubMed ID: 23055155)
1. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.
Zhu L; Baker SS; Gill C; Liu W; Alkhouri R; Baker RD; Gill SR
Hepatology; 2013 Feb; 57(2):601-9. PubMed ID: 23055155
[TBL] [Abstract][Full Text] [Related]
2. Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.
Yuan J; Baker SS; Liu W; Alkhouri R; Baker RD; Xie J; Ji G; Zhu L
J Gastroenterol Hepatol; 2014 Jun; 29(6):1292-8. PubMed ID: 24372861
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome and nonalcoholic fatty liver diseases.
Zhu L; Baker RD; Baker SS
Pediatr Res; 2015 Jan; 77(1-2):245-51. PubMed ID: 25310763
[TBL] [Abstract][Full Text] [Related]
4. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
[TBL] [Abstract][Full Text] [Related]
5. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
[TBL] [Abstract][Full Text] [Related]
6. Intestinal microbiota in patients with nonalcoholic fatty liver disease.
Mouzaki M; Comelli EM; Arendt BM; Bonengel J; Fung SK; Fischer SE; McGilvray ID; Allard JP
Hepatology; 2013 Jul; 58(1):120-7. PubMed ID: 23401313
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.
Del Chierico F; Nobili V; Vernocchi P; Russo A; De Stefanis C; Gnani D; Furlanello C; Zandonà A; Paci P; Capuani G; Dallapiccola B; Miccheli A; Alisi A; Putignani L
Hepatology; 2017 Feb; 65(2):451-464. PubMed ID: 27028797
[TBL] [Abstract][Full Text] [Related]
8. [The intestinal microbioma - more than just bacteria in the gut? a new mechanism in the pathogenesis of NASH?].
Sellge G; Streetz KL
Z Gastroenterol; 2014 May; 52(5):453-5. PubMed ID: 24824912
[No Abstract] [Full Text] [Related]
9. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis.
Nair S; Cope K; Risby TH; Diehl AM
Am J Gastroenterol; 2001 Apr; 96(4):1200-4. PubMed ID: 11316170
[TBL] [Abstract][Full Text] [Related]
10. The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais.
Sobhonslidsuk A; Chanprasertyothin S; Pongrujikorn T; Kaewduang P; Promson K; Petraksa S; Ongphiphadhanakul B
Biomed Res Int; 2018; 2018():9340316. PubMed ID: 29682571
[TBL] [Abstract][Full Text] [Related]
11. Lower gut microbiome diversity and higher abundance of proinflammatory genus
Astbury S; Atallah E; Vijay A; Aithal GP; Grove JI; Valdes AM
Gut Microbes; 2020 May; 11(3):569-580. PubMed ID: 31696774
[TBL] [Abstract][Full Text] [Related]
12. Structural changes in the gut microbiome of constipated patients.
Zhu L; Liu W; Alkhouri R; Baker RD; Bard JE; Quigley EM; Baker SS
Physiol Genomics; 2014 Sep; 46(18):679-86. PubMed ID: 25073603
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.
Raman M; Ahmed I; Gillevet PM; Probert CS; Ratcliffe NM; Smith S; Greenwood R; Sikaroodi M; Lam V; Crotty P; Bailey J; Myers RP; Rioux KP
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):868-75.e1-3. PubMed ID: 23454028
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.
Duarte SMB; Stefano JT; Miele L; Ponziani FR; Souza-Basqueira M; Okada LSRR; de Barros Costa FG; Toda K; Mazo DFC; Sabino EC; Carrilho FJ; Gasbarrini A; Oliveira CP
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):369-384. PubMed ID: 29482963
[TBL] [Abstract][Full Text] [Related]
16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
17. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.
Michail S; Lin M; Frey MR; Fanter R; Paliy O; Hilbush B; Reo NV
FEMS Microbiol Ecol; 2015 Feb; 91(2):1-9. PubMed ID: 25764541
[TBL] [Abstract][Full Text] [Related]
18. Increased fecal ethanol and enriched ethanol-producing gut bacteria
Mbaye B; Magdy Wasfy R; Borentain P; Tidjani Alou M; Mottola G; Bossi V; Caputo A; Gerolami R; Million M
Front Cell Infect Microbiol; 2023; 13():1279354. PubMed ID: 38035329
[TBL] [Abstract][Full Text] [Related]
19. Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis.
Qian M; Hu H; Yao Y; Zhao D; Wang S; Pan C; Duan X; Gao Y; Liu J; Zhang Y; Yang S; Qi LW; Wang L
Liver Int; 2020 Mar; 40(3):622-637. PubMed ID: 31782595
[TBL] [Abstract][Full Text] [Related]
20. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.
Yin X; Peng J; Zhao L; Yu Y; Zhang X; Liu P; Feng Q; Hu Y; Pang X
Syst Appl Microbiol; 2013 May; 36(3):188-96. PubMed ID: 23453736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
